CDNA
CareDx, Inc · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth -7.1% ·
share flow -16.1% ·
net new positions -7.7%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +15 | 33.34M | $949.64M | +15 | −1 |
| Q1 2026 | 83 | +3 | 34.73M | $602.98M | +6 | −3 |
| Q4 2025 | 80 | +2 | 35.05M | $660.43M | +2 | — |
| Q3 2025 | 16 | -1 | 19.38M | $281.84M | — | −1 |
| Q2 2025 | 14 | -2 | 18.42M | $359.99M | — | −2 |
| Q1 2025 | 13 | -1 | 10.08M | $178.96M | — | −1 |
| Q4 2024 | 14 | 0 | 12.01M | $257.21M | +1 | −1 |
| Q3 2024 | 13 | +2 | 9.17M | $286.29M | +2 | — |
| Q2 2024 | 11 | — | 12.97M | $201.49M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 2.48M | -6.6% | $44.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | ARK Investment Management ✦ | 2.35M | -2.6% | $41.67M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.28M | +3.7% | $22.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.28M | +3.7% | $22.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 1.24M | -13.6% | $21.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 793.81K | +55.6% | $14.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 793.81K | +55.6% | $14.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 783.01K | -31.9% | $13.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 783.01K | -31.9% | $13.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 459.89K | -16.0% | $8.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 459.89K | -16.0% | $8.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 459.89K | -16.0% | $8.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 459.89K | -16.0% | $8.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 459.89K | -16.0% | $8.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 321.91K | -31.3% | $5.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Wellington Management ✦ | 159.44K | -3.6% | $2.83M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 159.44K | -3.6% | $2.83M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Wellington Management ✦ | 159.44K | -3.6% | $2.83M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Wellington Management ✦ | 159.44K | -3.6% | $2.83M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Millennium Management ✦ | 102.61K | -83.5% | $1.82M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Marshall Wace ✦ | 43.87K | -84.8% | $778,729 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Marshall Wace ✦ | 43.87K | -84.8% | $778,729 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Arrowstreet Capital ✦ | 38.58K | +12.9% | $684,795 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | T. Rowe Price ✦ | 29.42K | +8.5% | $523,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Point72 Asset Management | $9.97M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 189 holders, 52.20M shares, $899.83M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.